REFERENCES
- Anderson J. J., Bravi D., Ferrai R., Davis T. L., Baronti F., Chase T. N., Dagani F. No evidence for altered muscle mitochondrial function in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1993; 56: 477–480, [PUBMED], [INFOTRIEVE]
- Aomi Y., Chen C. S., Nakada K., et al. Cytoplasmic transfer of platelet mtDNA from elderly patients with Parkinson's disease to mtDNA-less HeLA cells restores complete mitochondrial respiratory function. Biochemical Biophysical Res Commun 2001; 280: 265–273, [CROSSREF], [CSA]
- Barroso N., Campos Y., Huertas R., et al. Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson's disease. Clin Chem 1993; 39: 667–669, [PUBMED], [INFOTRIEVE]
- Benecke R., Strümper P., Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 1993; 116: 1451–1463, [PUBMED], [INFOTRIEVE], [CSA]
- Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., Greenamyre J. T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neuroscience 2000; 3: 1301–1306, [CROSSREF]
- Bindoff L. A., Birch-Machin M. A., Cartlidge N. E. F., Parker W. D., Jr., Turnbull D. M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. Journal of Neurological Science 1991; 104: 203–208, [CROSSREF]
- Blake C. I., Spitz E., Leehey M., Hoffer B. J., Boyson S. J. Platelet mitochondrial respiratory chain function in Parkinson's disease. Movement Disorders 1997; 12: 3–8, [PUBMED], [INFOTRIEVE], [CSA]
- Blin O., Desnuelle C., Rascol O., et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. Journal of Neurological Science 1994; 125: 95–101, [CROSSREF], [CSA]
- Bonifati V., Rizzu P., van Baren M. J., et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256–259, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bravi D., Anderson J. J., Dagani F., et al. Effect of aging and dopaminomimetic therapy on mitochondrial function in Parkinson's disease. Movement Disorders 1992; 7: 228–231, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Browne S. E., Bowling A. C., Macgarvey U., et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Annals of Neurology 1997; 41: 646–653, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cardellach F., Marti M. J., Fernandez-Sola J., et al. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 1993; 43: 2258–2262, [PUBMED], [INFOTRIEVE], [CSA]
- Da Prada M., Cesura A. M., Launay J. M., Richards J. G. Platelets as a model for neurones?. Experientia 1994; 4: 115–126
- Di Donato S., Zeviani M., Giovannini P., et al. Respiratory chain and mitochondrial DNA in muscle and brain Parkinson's disease patients. Neurology 1993; 43: 2262–2268, [CSA]
- Fahn S., Elton R. L., UPDRS development committee. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease Volume 2, S. Fahn, C. D. Marsden, M. Goldstein, D. B. Calne. Njimac Millan, Florham Park, NJ 1987; pp. 153–163
- Farrer M., Gwinn-Hardy K., Muenter M., et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Human Molecular Genetic 1999; 8: 81–85, [CROSSREF], [CSA]
- Funayama M., Hasegawa K., Kowa H., Saito M., Tsuji S., Obata F. A new locus for Parkinson's disease (PARK 8) maps to chromosome 12p11.2–q13.1. Annals of Neurology 2002; 5: 296–301, [CROSSREF]
- Furukawa Y., Vigouroux S., Wong H., et al. Brain proteasomal function in sporadic Parkinson's disease and related disorders. Annals of Neurology 2002; 51: 779–782, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gasser T., Muller-Myhsok B., Wszolek Z. K., et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genetics 1998; 18: 262–265, [CROSSREF]
- Gu M., Cooper J. M., Taanman J. W., Schapira A. H. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol 1998; 44: 177–186, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Haas R. H., Nasirian F., Nakono K., Ward D., Pay M., Hill R., Shults C. W. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Annals of Neurology 1995; 37: 714–722, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hattori N., Tanaka M., Ozawa T., Mizuno Y. Immunohistochemical studies on complexes I, II, III and IV of mitochondria in Parkinson's disease. Annals of Neurology 1991; 30: 563–571, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hicks A. A., Petursson H., Jonsson T., et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Annals of Neurology 2002; 52: 549–555, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hoehn M. M., Yahr M. D. Parkinsonism: Onset, progression, and mortality. Neurology 1967; 17: 419–423
- Janetzky B., Hauck S., Youdin M. D., et al. Unaltered acotinase activity, but decreased complex I activity in subsantia nigra pars compacta of patients with Parkinson's disease. Neuroscience Letters 1994; 169: 126–128, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605–608, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Klawans H. L., Stein R. W., Tanner C. W., Goetz C. G. A pure parkinsonian syndrome following acute carbon monoxide intoxication. Archives of Neurology 1982; 39: 302–304, [PUBMED], [INFOTRIEVE]
- Krige D., Carroll M. T., Cooper J. M., Marsden C. D., Schapira A. H. V. Platelet mitochondrial function in Parkinson's disease. Annals of Neurology 1992; 32: 782–788, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Krüger R., Kuhn W., Muller T., et al. Ala30pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998; 18: 106–108, [CROSSREF]
- Landsbury P. T., Brice A. Genetic of Parkinson's disease and biochemical studies of implicated gene products. Current Opinion in Genetics Development 2002; 12: 299–306, [CROSSREF], [CSA]
- Langston J. W., Ballard P., Tetrud J. W., Irwin I. Chronic parkinsonism in humans due to a product of meperedine-analog synthesis. Science 1983; 219: 979–980, [PUBMED], [INFOTRIEVE]
- Le W. D., Xu P., Jankovic J., Jiang H., Appel S. H., Smith R. G., Vassilatis D. K. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genetics 2003; 33: 85–89, [CROSSREF]
- Lestienne P., Nelson I., Reiderer P., et al. Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. Journal of Neurochemistry 1990; 55: 1810–1812, [PUBMED], [INFOTRIEVE]
- Lodi R., Rajagopalan B., Bradley J. L., et al. Mitochondrial dysfunction in Friedreich's ataxia: From pathogenesis to treatment perspectives. Free Radical Research 2002; 36: 461–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Journal of Biological Chemistry 1951; 193: 265–275, [PUBMED], [INFOTRIEVE]
- Mann V. Y., Cooper J. M., Krige D., Daniel S. E., Schapira A. H. V., Marsden C. D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992; 115: 333–342, [PUBMED], [INFOTRIEVE]
- Maraganore D. M., Farrer M. J., Hardy J. A., Lincoln S. J., McDonnel S. K., Rocca W. A. Case control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 1999; 53: 1858–1860, [PUBMED], [INFOTRIEVE], [CSA]
- Martin M. A., Molina J. A., Jimenez-Jimenez F. J., Benito-Leon J., Orti-Pareja M., Campos Y., Arenas J. Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Neurology 1996; 46: 1343–1346, [PUBMED], [INFOTRIEVE], [CSA]
- Mc Naught K.St. P., Olanow C. W., Haliwell, Isacson O., Jenner P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nature Reviews Neuroscience 2001; 2: 89–94
- Mena I. Manganese poisoning. Handbook of Clinical Neurology. Part I. Intoxications of the Nervous system, P. J. Vinken, G. W. Bruyn. Elsevier Science, Amsterdam 1995; Vol. 36.: pp. 217–237
- Mizuno Y., Ohta S., Tanaka M., et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989; 163: 1450–1455, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nakagawa-Hattori Y., Yoshino H., Kondo T., Mizuno Y., Horai S. Is Parkinson's disease a mitochondrial disorder?. Journal of Neurological Science 1995; 107: 29–33, [CROSSREF], [CSA]
- Parker W. D., Jr., Boyson S. J., Parks J. K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Annals of Neurology 1989; 26: 719–723, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Parker W. D., Parks J., Filley C. M., et al. Electron transport chain defects in Alzheimer's disease. Neurology 1994; 44: 1090–1096, [PUBMED], [INFOTRIEVE], [CSA]
- Polymeropoulos M. H., Lavedan C., Leroy E., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045–2047, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reichmann H., Janetzsky Bi Bischof F., et al. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. European Neurology 1994; 34: 263–267, [PUBMED], [INFOTRIEVE], [CSA]
- Sandy M. S., Langston J. W., Smith M. T., Dimeonte D. A. PCR analysis of platelet mtDNA: Lack of specific changes in Parkinson's disease. Movement Disorders 1993; 8: 74–82, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schapira A. H. V., Cooper J. M., Dexter D., Jenner P., Marsden C. D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989; 1: 1269, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., Marsden C. D. Mitochondrial Complex I deficiency in Parkinson's disease. Journal of Neurochemistry 1990a; 54: 823–827, [PUBMED], [INFOTRIEVE]
- Schapira A. H. V., Mann V. M., Cooper J. M., et al. Anatomic and disease specifity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. Journal of Neurochemistry 1990b; 55: 2142–2145, [PUBMED], [INFOTRIEVE]
- Schapira A. H. V., Warner T., Gash M. T., et al. Complex I function in familial and sporadic dystonia. Annals of Neurology 1997; 41: 556–559, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shoffner J. M., Watts R. L., Juncos J. L., Torroni A., Wallace D. C. Mitochondrial Oxidative Phosphorylation defects in Parkinson's disease. Annals of Neurology 1991; 30: 332–339, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Simon D. K., Mayeux R., Maarder K., Kowall N. W., Beal M. F., Johns D. R. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology 2000; 54: 703–709, [PUBMED], [INFOTRIEVE], [CSA]
- Speciale S. G. MPTP: Insights into parkinsonian neurodegeneration. Neurotoxicology and Teratology 2002; 24: 607–620, [PUBMED], [INFOTRIEVE], [CSA]
- Swerdlow R. H., Parks J. K., Miller S. W., et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Annals of Neurology 1996; 40: 663–671, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Swerdlow R. H., Parks J. K., Davis J. N., et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Annals of Neurology 1998; 44: 873–881, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Swerdlow R. H., Parks J. K., Cassarino D. S., et al. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Exp. Neurology 2001; 169: 479–485, [CROSSREF], [CSA]
- Tanner C. M., Hubble J. P., Chan P. Epidemiology and genetics of Parkin-son's disease. Movement disorders: Neurologic principles and practice, R. L. Watts, W. C. Koller. McGraw Hill., New York 1997; pp. 137–152
- Trounce I. A., Kim Y. L., Jun A. S., Wallace D. C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymology 1996; 264: 484–509
- Valente E. M., Abou-Sleiman P. M., Caputo V., et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1. Science 2004, published online 15 April 2004 (in Science Express)
- van der Walt J. M., Nicodemus K. K., Martin E. R., et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson Disease. American Journal of Human Genetics. 2003; 72: 804–811, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vives-Bauza C., Andreu A. L., Manfredi G., Beal M. F., Janetzky B., Gruenewald T. H., Lin M. T. Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem Biophys Res Commun 2002; 290: 1593–1601, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wooten G. F. Neurochemistry and neuropharmacology of Parkinson's disease. Movement disorders: Neurologic principles and practice, R. L. Watts, W. C. Koller. McGraw Hill, New York 1997a; pp. 153–160
- Wooten G. F., Currie L. J., Bennett J. P., Trugman J. M., Harrison M. B., Parker W. D. Maternal inheritance in Parkinson's disease. Annals of Neurology 1997b; 41: 265–268, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yoshino H., Nakagawa-Hattori Y., Kondo T., Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. Journal of Neural Transm Parkinson's Disease Dement Sect 1992; 4: 27–34